Cargando…
Balancing risk versus benefit: the elderly patient’s perspective on warfarin therapy
Warfarin therapy is underused in the target at-risk elderly population. Clinicians perceive that older patients are reluctant to use this therapy, however the perspective of patients or their carers has yet to be explored. OBJECTIVE: To explore in-depth the perspectives of elderly patients and/or th...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Centro de Investigaciones y Publicaciones Farmaceuticas
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139749/ https://www.ncbi.nlm.nih.gov/pubmed/25152787 |
_version_ | 1782331406252244992 |
---|---|
author | Bajorek, Beata V. Ogle, Susan J. Duguid, Margaret J. Shenfield, Gillian M. Krass., Ines |
author_facet | Bajorek, Beata V. Ogle, Susan J. Duguid, Margaret J. Shenfield, Gillian M. Krass., Ines |
author_sort | Bajorek, Beata V. |
collection | PubMed |
description | Warfarin therapy is underused in the target at-risk elderly population. Clinicians perceive that older patients are reluctant to use this therapy, however the perspective of patients or their carers has yet to be explored. OBJECTIVE: To explore in-depth the perspectives of elderly patients and/or their carers regarding the use of warfarin therapy. METHOD: A qualitative study, using semi-structured group interviews was undertaken. The audio-taped discussions were transcribed verbatim, then thematically analysed to identify emergent themes. Group discussions were conducted at a major Sydney teaching hospital, over a 2-month period. Individuals aged 65 years or older (and/or their carers) who were using long-term (6 months) warfarin therapy were recruited by voluntary response to study flyers. RESULTS: 17 patients and carers (mean age 77.2 SD=7.5 years) participated in one of two focus groups. Five core themes emerged regarding warfarin therapy: inadequate knowledge and understanding about it, patients/carers variable experience of information provision, cycle of reactions to being on it, issues in its practical management, and the spectrum of experiences with it. Overall, participants were very accepting of the therapy, describing a high level of compliance, despite initial fears and anxieties, and a relative lack of knowledge. Patients felt somewhat abandoned in their management of warfarin due to the lack of ongoing support services in the community, and inadequate information provision. CONCLUSIONS: Elderly patients and their carers appear to be quite accepting of warfarin therapy, in contrast to the perceptions of health care professionals. More effort is needed, however, in terms of information provision, particularly in the form of community-based services, to assist patients in the long-term management of warfarin. |
format | Online Article Text |
id | pubmed-4139749 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Centro de Investigaciones y Publicaciones Farmaceuticas |
record_format | MEDLINE/PubMed |
spelling | pubmed-41397492014-08-22 Balancing risk versus benefit: the elderly patient’s perspective on warfarin therapy Bajorek, Beata V. Ogle, Susan J. Duguid, Margaret J. Shenfield, Gillian M. Krass., Ines Pharm Pract (Granada) Original Research Warfarin therapy is underused in the target at-risk elderly population. Clinicians perceive that older patients are reluctant to use this therapy, however the perspective of patients or their carers has yet to be explored. OBJECTIVE: To explore in-depth the perspectives of elderly patients and/or their carers regarding the use of warfarin therapy. METHOD: A qualitative study, using semi-structured group interviews was undertaken. The audio-taped discussions were transcribed verbatim, then thematically analysed to identify emergent themes. Group discussions were conducted at a major Sydney teaching hospital, over a 2-month period. Individuals aged 65 years or older (and/or their carers) who were using long-term (6 months) warfarin therapy were recruited by voluntary response to study flyers. RESULTS: 17 patients and carers (mean age 77.2 SD=7.5 years) participated in one of two focus groups. Five core themes emerged regarding warfarin therapy: inadequate knowledge and understanding about it, patients/carers variable experience of information provision, cycle of reactions to being on it, issues in its practical management, and the spectrum of experiences with it. Overall, participants were very accepting of the therapy, describing a high level of compliance, despite initial fears and anxieties, and a relative lack of knowledge. Patients felt somewhat abandoned in their management of warfarin due to the lack of ongoing support services in the community, and inadequate information provision. CONCLUSIONS: Elderly patients and their carers appear to be quite accepting of warfarin therapy, in contrast to the perceptions of health care professionals. More effort is needed, however, in terms of information provision, particularly in the form of community-based services, to assist patients in the long-term management of warfarin. Centro de Investigaciones y Publicaciones Farmaceuticas 2009 2009-03-15 /pmc/articles/PMC4139749/ /pubmed/25152787 Text en Copyright: © Pharmacy Practice http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY-NC-ND 3.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Research Bajorek, Beata V. Ogle, Susan J. Duguid, Margaret J. Shenfield, Gillian M. Krass., Ines Balancing risk versus benefit: the elderly patient’s perspective on warfarin therapy |
title | Balancing risk versus benefit: the elderly patient’s perspective on warfarin therapy |
title_full | Balancing risk versus benefit: the elderly patient’s perspective on warfarin therapy |
title_fullStr | Balancing risk versus benefit: the elderly patient’s perspective on warfarin therapy |
title_full_unstemmed | Balancing risk versus benefit: the elderly patient’s perspective on warfarin therapy |
title_short | Balancing risk versus benefit: the elderly patient’s perspective on warfarin therapy |
title_sort | balancing risk versus benefit: the elderly patient’s perspective on warfarin therapy |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139749/ https://www.ncbi.nlm.nih.gov/pubmed/25152787 |
work_keys_str_mv | AT bajorekbeatav balancingriskversusbenefittheelderlypatientsperspectiveonwarfarintherapy AT oglesusanj balancingriskversusbenefittheelderlypatientsperspectiveonwarfarintherapy AT duguidmargaretj balancingriskversusbenefittheelderlypatientsperspectiveonwarfarintherapy AT shenfieldgillianm balancingriskversusbenefittheelderlypatientsperspectiveonwarfarintherapy AT krassines balancingriskversusbenefittheelderlypatientsperspectiveonwarfarintherapy |